Cargando…

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients with Acute Coronary Syndrome

Introduction High-sensitivity C-reactive protein (hs-CRP) has emerged to be a very useful and reliable clinical marker of primary as well as secondary cardiovascular morbidity and mortality. Elevated hs-CRP contributes to underlying atherogenesis and worsens disease prognosis. Along with their lipid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Besham, Shah, Mir Ali Asghar, Kumar, Rajesh, Kumar, Jai, Memon, Aurangzeb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689481/ https://www.ncbi.nlm.nih.gov/pubmed/31423377 http://dx.doi.org/10.7759/cureus.4898

Ejemplares similares

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome
por: Umrani, Salman, et al.
Publicado: (2020)

The Effect of Preoperative Hematocrit Levels on Early Outcomes After Coronary Artery Bypass Graft
por: Kumar, Suresh, et al.
Publicado: (2021)

Comparison of Iron Profile in Patients With and Without Coronary Heart Disease
por: Amar, Zain, et al.
Publicado: (2021)

Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study
por: Kumar, Pardeep, et al.
Publicado: (2021)

Correlation of Leptin With Acute Myocardial Infarction: A Case Control Study
por: Syed, Asghar Hussain, et al.
Publicado: (2020)

Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome
por: Khurana, Sushant, et al.
Publicado: (2015)

Barriers Experienced by Medical Students in Conducting Research at Undergraduate Level
por: Kumar, Jai, et al.
Publicado: (2019)

Accuracy of Resolution of ST-Segment Elevation in Electrocardiogram to Determine the Patency of Infarct-Related Artery
por: Shaikh, Muhammed Kashif, et al.
Publicado: (2021)

Role of Cod Liver Oil in Reducing Elevated Lipid Parameters
por: Fatima, Faryal, et al.
Publicado: (2021)

Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia
por: Aleem, Mudassar, et al.
Publicado: (2022)

Comparison of the Prevalence of Erectile Dysfunction Between Hypertensive and Normotensive Participants: A Case-Control Study
por: Kumar, Suresh, et al.
Publicado: (2020)

Impact of Hypothyroidism on Outcomes of Percutaneous Coronary Intervention with Coronary Atherectomy for Calcified Coronary Lesions: A Propensity-matched Analysis
por: Desai, Rupak, et al.
Publicado: (2018)

Frequency of Cardiovascular Manifestation in Patients With Rheumatoid Arthritis
por: Kumar, Pardeep, et al.
Publicado: (2021)

Real-World Clinical Experience of Rosuvastatin as a Lipid-Lowering Therapy for Primary and Secondary Prevention of Cardiovascular Events (REAL ROSE)
por: Mehta, Ashwani, et al.
Publicado: (2022)

Depression, Anxiety, and Stress Among Final-year Medical Students
por: Kumar, Besham, et al.
Publicado: (2019)

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
por: Golshani, Samad, et al.
Publicado: (2022)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018)

Peripheral Artery Disease as a Predictor of Coronary Artery Disease in Patients Undergoing Coronary Angiography
por: Kumar, Ashok, et al.
Publicado: (2021)

A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol
por: Niedzielski, Mateusz, et al.
Publicado: (2021)

Role of Cod Liver Oil in Preventing Myocardial Infarction
por: Mal, Madho, et al.
Publicado: (2021)

Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
por: Barakat, Lolwa, et al.
Publicado: (2013)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
por: Han, Eugene, et al.
Publicado: (2017)

Incidence of Cardiac Arrhythmias in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention and Associated Outcomes During the First 24 Hours
por: Shah, Jehangir A, et al.
Publicado: (2021)

Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects
por: Mohamed, Mohamed‐Eslam F., et al.
Publicado: (2021)

Coronary Arteriovenous Fistula Originating From the Left Main Coronary Artery
por: Kumar, Dilpat, et al.
Publicado: (2022)

Clinical Rhabdomyolysis With Acute Kidney Injury Secondary to High-Intensity Rosuvastatin Use: A Case Report
por: Chitralli, Deepak, et al.
Publicado: (2020)

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
por: Clearfield, Michael B, et al.
Publicado: (2006)

Role of Coenzyme Q10 in Prophylaxis of Myocardial Infarction
por: Shah, Iftikhar Ali, et al.
Publicado: (2021)

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction
por: Zhou, Langping, et al.
Publicado: (2023)

Comparison of Percutaneous Coronary Intervention Outcomes Among Patients With Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease Overlap, and Pickwickian Syndrome (Obesity Hypoventilation Syndrome)
por: Desai, Rupak, et al.
Publicado: (2022)

In vivo and In vitro Drug Interactions Study of Glimepride with Atorvastatin and Rosuvastatin
por: Galani, VJ, et al.
Publicado: (2010)

Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
por: Adel, Esraa M., et al.
Publicado: (2022)

Atorvastatin as a Rare Primary Cause of Drug-Induced Angioedema: A Case Report
por: Voloshyna, Diana, et al.
Publicado: (2022)

Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial
por: Lee, Yong-Joon, et al.
Publicado: (2023)

A Case Report of High-Risk Percutaneous Coronary Intervention of Left Main Coronary Artery With Cardiogenic Shock
por: Khanal, Suraj, et al.
Publicado: (2023)

A Young Heart With Coronary Dissection
por: Kumar, Kelash, et al.
Publicado: (2022)

Echocardiographic and Angiographic Assessment of Right Ventricular Function and Right Coronary Artery Stenosis in Acute Inferior Wall Myocardial Infarction
por: Kumar, Rajneesh, et al.
Publicado: (2023)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Efficacy comparison of atorvastatin versus rosuvastatin on blood lipid and microinflammatory state in maintenance hemodialysis patients
por: Tian, Jianwei, et al.
Publicado: (2016)

Acute Myocarditis Presenting as Acute Coronary Syndrome
por: Mosebach, Christian M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t309f4ud1t4d3li0kagb7ms6l2